Loading…
Loading…
The sale occurred on Aug. 21 and was valued at approximately $541,000. The disposition reduced the executive's direct equity holdings by 7%.
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
Bank of New York Mellon Corp acquired a new position in shares of Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 94,045 shares of the company's stock, valued at approximately $43,800,000. Bank of New York Mellon Corp owned approximately
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Deutsche Bank AG acquired a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 16,747 shares of the company's stock, valued at approximately $7,800,000. Deutsche Bank AG owned about 0.13% of Chemed
NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
Abacus FCF Advisors LLC acquired a new stake in shares of Chemed Corporation (NYSE: CHE) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 8,239 shares of the company's stock, valued at approximately $3,837,000. Abacus FCF Advisors LLC owned